STOCK TITAN

[Form 4] UiPath, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

UiPath (PATH) insider transaction: The company’s Chief Accounting Officer reported selling 5,000 shares of Class A common stock on 10/22/2025 (Transaction Code S) under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $15.4673, with trade prices ranging from $15.3200 to $15.8000. Following this sale, the reporting person beneficially owns 182,776 shares, held directly.

UiPath (PATH) insider transaction: Il Responsabile della contabilità della società ha riferito di aver venduto 5.000 azioni ordinarie di Classe A il 22/10/2025 (Codice di Transazione S) nell'ambito di un piano di negoziazione Rule 10b5-1. Le azioni sono state vendute a un prezzo medio ponderato di $15,4673, con prezzi di negoziazione che variavano da $15,3200 a $15,8000. Dopo questa vendita, la persona indicata possiede direttamente 182.776 azioni.

Transacción de insider de UiPath (PATH): El Director de Contabilidad de la empresa informó la venta de 5,000 acciones de Clase A de valor nominal en el 22/10/2025 (Código de Transacción S) bajo un plan de negociación Rule 10b5-1. Las acciones se vendieron a un precio medio ponderado de $15,4673, con precios de operación que oscilaban entre $15,3200 y $15,8000. Tras esta venta, la persona que reporta posee beneficiosamente 182,776 acciones, mantenidas directamente.

UiPath (PATH) 내부자 거래: 회사의 최고 회계 책임자가 2025년 10월 22일(거래 코드 S)에 따라 Rule 10b5-1 거래 계획 하에 A클래스 보통주 5,000주를 매도했다고 보고했습니다. 매도 주식은 가중 평균가 $15.4673로 매매되었으며 체결가는 $15.3200~$15.8000 범위였습니다. 이 매도로 보고자는 직접 보유한 182,776주를 유리하게 소유하게 됩니다.

Transaction d'initié UiPath (PATH) : Le directeur financier de l'entreprise a déclaré avoir vendu 5 000 actions ordinaires de classe A le 22/10/2025 (Code de transaction S) dans le cadre d'un plan de négociation Rule 10b5-1. Les actions ont été vendues à un prix moyen pondéré de 15,4673 $, les prix des transactions allant de 15,3200 $ à 15,8000 $. Suite à cette vente, la personne déposant le rapport détient directement 182 776 actions.

UiPath (PATH) Insider-Transaktion: Der Chief Accounting Officer des Unternehmens berichtete, am 22.10.2025 (Transaktionscode S) im Rahmen eines Rule-10b5-1-Handelsplans 5.000 Stammaktien der Klasse A verkauft zu haben. Die Aktien wurden zu einem gewichteten Durchschnittspreis von 15,4673 $ verkauft, wobei die Handelspreise zwischen 15,3200 $ und 15,8000 $ lagen. Nach diesem Verkauf besitzt die meldende Person direkt 182.776 Aktien.

صفقة داخل UiPath (PATH): أفاد كبير موظفي المحاسبة بالشركة بأنه باع 5,000 سهم من أسهم فئة A العادية في 22/10/2025 (رمز الصفقة S) بموجب خطة تداول Rule 10b5-1. بُيعت الأسهم بسعر متوسط مرجح قدره 15.4673 دولار، مع ترواح أسعار التداول بين 15.3200 دولار و15.8000 دولار. عقب هذا البيع، يمتلك المبلغ عنه بشكل مباشر 182,776 سهمًا.

Positive
  • None.
Negative
  • None.

UiPath (PATH) insider transaction: Il Responsabile della contabilità della società ha riferito di aver venduto 5.000 azioni ordinarie di Classe A il 22/10/2025 (Codice di Transazione S) nell'ambito di un piano di negoziazione Rule 10b5-1. Le azioni sono state vendute a un prezzo medio ponderato di $15,4673, con prezzi di negoziazione che variavano da $15,3200 a $15,8000. Dopo questa vendita, la persona indicata possiede direttamente 182.776 azioni.

Transacción de insider de UiPath (PATH): El Director de Contabilidad de la empresa informó la venta de 5,000 acciones de Clase A de valor nominal en el 22/10/2025 (Código de Transacción S) bajo un plan de negociación Rule 10b5-1. Las acciones se vendieron a un precio medio ponderado de $15,4673, con precios de operación que oscilaban entre $15,3200 y $15,8000. Tras esta venta, la persona que reporta posee beneficiosamente 182,776 acciones, mantenidas directamente.

UiPath (PATH) 내부자 거래: 회사의 최고 회계 책임자가 2025년 10월 22일(거래 코드 S)에 따라 Rule 10b5-1 거래 계획 하에 A클래스 보통주 5,000주를 매도했다고 보고했습니다. 매도 주식은 가중 평균가 $15.4673로 매매되었으며 체결가는 $15.3200~$15.8000 범위였습니다. 이 매도로 보고자는 직접 보유한 182,776주를 유리하게 소유하게 됩니다.

Transaction d'initié UiPath (PATH) : Le directeur financier de l'entreprise a déclaré avoir vendu 5 000 actions ordinaires de classe A le 22/10/2025 (Code de transaction S) dans le cadre d'un plan de négociation Rule 10b5-1. Les actions ont été vendues à un prix moyen pondéré de 15,4673 $, les prix des transactions allant de 15,3200 $ à 15,8000 $. Suite à cette vente, la personne déposant le rapport détient directement 182 776 actions.

UiPath (PATH) Insider-Transaktion: Der Chief Accounting Officer des Unternehmens berichtete, am 22.10.2025 (Transaktionscode S) im Rahmen eines Rule-10b5-1-Handelsplans 5.000 Stammaktien der Klasse A verkauft zu haben. Die Aktien wurden zu einem gewichteten Durchschnittspreis von 15,4673 $ verkauft, wobei die Handelspreise zwischen 15,3200 $ und 15,8000 $ lagen. Nach diesem Verkauf besitzt die meldende Person direkt 182.776 Aktien.

صفقة داخل UiPath (PATH): أفاد كبير موظفي المحاسبة بالشركة بأنه باع 5,000 سهم من أسهم فئة A العادية في 22/10/2025 (رمز الصفقة S) بموجب خطة تداول Rule 10b5-1. بُيعت الأسهم بسعر متوسط مرجح قدره 15.4673 دولار، مع ترواح أسعار التداول بين 15.3200 دولار و15.8000 دولار. عقب هذا البيع، يمتلك المبلغ عنه بشكل مباشر 182,776 سهمًا.

UiPath (PATH) 内幕交易: 公司的首席会计官报告在 2025/10/22(交易代码 S)在 Rule 10b5-1 交易计划下出售了 5,000 股 A 类普通股。该等股票的成交价格按加权平均价格为 15.4673 美元,交易价格区间为 15.3200 美元至 15.8000 美元。此笔交易后,申报人直接持有 182,776 股。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ramani Hitesh

(Last) (First) (Middle)
C/O UIPATH, INC., ONE VANDERBILT AVENUE
60TH FLOOR

(Street)
NEW YORK NY 10017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/22/2025 S 5,000(1) D $15.4673(2) 182,776 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
2. The range of prices for the transactions reported was from $15.3200 to $15.8000. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
Remarks:
/s/ Brad Brubaker, Attorney-in-Fact 10/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did UiPath (PATH) disclose in this Form 4?

A sale of 5,000 Class A shares by the Chief Accounting Officer on 10/22/2025 under a Rule 10b5-1 plan.

What was the sale price for the PATH shares?

A weighted average price of $15.4673, with individual sale prices ranging from $15.3200 to $15.8000.

How many PATH shares does the insider own after the sale?

The reporting person now beneficially owns 182,776 shares, held directly.

What is the insider’s role at UiPath (PATH)?

The reporting person is an Officer, serving as Chief Accounting Officer.

What transaction code is shown in the filing?

Transaction Code S, indicating an open market or private sale of non-derivative securities.

Was the sale made under a pre-arranged plan?

Yes. The filing states the sale was made under a qualified Rule 10b5-1 trading plan.
Uipath Inc

NYSE:PATH

PATH Rankings

PATH Latest News

PATH Latest SEC Filings

PATH Stock Data

8.20B
409.52M
9.44%
82.2%
10.47%
Software - Infrastructure
Services-prepackaged Software
Link
United States
NEW YORK